Figure 2From: Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis Decision tree for the threatened preterm birth models. The decision tree used to compare standard care (no treatment) with administration of magnesium sulphate to patients in whom preterm birth at < 32+0 weeks gestation is threatened.Back to article page